小儿呼吸道合胞病毒性肺炎中西医对照临床疗效多属性综合评价  

Multi-attribute evaluation of the clinical effect dfferences between Chinese medicine and western medicine in the treatment of pediatric RSV pneumonia

作　　者：胥会英[1] 韩新民[2] 黄建萍[1] 

机构地区：[1]无锡市第三人民医院儿科,江苏无锡214041 [2]南京中医药大学儿科教研室,江苏南京210046

出　　处：《中医儿科杂志》2013年第1期23-27,共5页Journal of Pediatrics of Traditional Chinese Medicine

摘　　要：目的:评价小儿呼吸道合胞病毒性肺炎痰热闭肺证型中西医对照临床疗效的优劣。方法:选用成本-效果比、不良反应率、住院时间和远期疗效4个属性作为综合疗效的指标,运用TOPSIS法进行疗效评价,通过分析权重系数和属性值的动态范围以确定评价结果的稳定度。结果:中药和西药治疗方案与理想方案的相对接近程度分别为0.967和0.033,中药治疗方案更理想,权重系数和各属性的动态范围较大,评价结果稳定。结论:中药治疗方案的综合疗效优于西药治疗方案,用中药方案治疗小儿呼吸道合胞病毒性肺炎痰热闭肺证型值得向社会推广。Objective： To compare the superiority between the traditional Chinese and western medicine treatment of pediatric respiratory synctial virus pneumonia of phlegm heat blocking the lung. Methods： The twotreatments were compared in the following four attributes： cost-effect of ratio, rate of adverse reaction, hospitalization time and long-term effect. The method of TOPSIS was used to evaluate the curative effect, and analysis of the weight coefficient and the attribute value of the dynamic range was used to determine the stability of the evaluation. Results： Comparison of clinical comprehensive efficacy between traditional Chinese medicine and western medicine treatment plans ： The relative closeness to the ideal scheme was respectively 0. 967 and 0. 033, Chinese medicine treatment was more ideal. The weight coefficient and the properties of the large dynamic range were wide, and evaluation results were stable. Conclusion： Comprehensive efficacy of traditional Chinese medicine is superior to that of western medicine treatment. Traditional Chinese medicine in treating phlegm-heat blocking lung syndrome ofRSV pneumonia can be popularized.

关 键 词：呼吸道合胞病毒性肺炎 中西医对照治疗 多属性综合评价 

分 类 号：R725.6[医药卫生—儿科]